02 January 2026
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.
CITIUS ONCOLOGY, INC.
CIK: 1851484•2 Annual Reports•Latest: 2025-12-23
10-K / December 23, 2025
Revenue:N/A
Income:-$24,761,369
10-K / April 16, 2024
Revenue:N/A
Income:$2,419,304
10-K / December 23, 2025
Summary (based only on the provided text)
-
The provided excerpt is a table-of-contents fragment for "PART I" of a filing. It lists the following Item headings and corresponding page numbers:
- Item 1. Business — page 1
- Item 1A. Risk Factors — page 18
- Item 1B. Unresolved Staff Comments — page 47
- Item 1C. Cybersecurity — page 47
- Item 2. Properties — page 48
- Item 3. Legal Proceedings — page 48
- Item 4. Mine Safety Disclosures — page 48
-
No substantive description of the company’s business operations is included in the excerpt. The excerpt does not contain any information about:
- what the company actually does (products/services, markets, business model),
- number of customers,
- number of employees,
- revenue or income figures,
- or any other quantitative operational or financial details.
If you provide the text from Item 1 (Business) or other substantive sections, I can produce a detailed, specific summary including counts and financial figures that appear in those sections.
